Plasma Aβ42 and Total Tau Predict Cognitive Decline in Amnestic Mild Cognitive Impairment

Levels of amyloid-β (Aβ) and tau peptides in brain have been associated with Alzheimer disease (AD). The current study investigated the abilities of plasma Aβ42 and total-tau (t-tau) levels in predicting cognitive decline in subjects with amnestic mild cognitive impairment (MCI). Plasma Aβ42 and t-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ting-Bin, Lee, Yi-Jung, Lin, Szu-Ying, Chen, Jun-Peng, Hu, Chaur-Jong, Wang, Pei-Ning, Cheng, Irene H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764975/
https://www.ncbi.nlm.nih.gov/pubmed/31562355
http://dx.doi.org/10.1038/s41598-019-50315-9

Ejemplares similares

Ejemplares similares